Utah Medical Prod (UTMD) 64.61 $UTMD
Utah Medical Products, Inc. Reports Financial Performance for Second Quarter 2016
Marketwire Canada - Tue Jul 26, 8:01AM CDT
SALT LAKE CITY, UT--(Marketwired - Jul 26, 2016) - In the second calendar quarter (2Q) and first half (1H) of 2016, Utah Medical Products, Inc. (NASDAQ: UTMD) continued to achieve results which are on track to meet its previously announced goals for 2016.
UTMD: 64.61 (-0.46)
Utah Medical Products, Inc. Announces Quarterly Dividend
ACCESSWIRE - Tue May 03, 9:00AM CDT
SALT LAKE CITY, UT / ACCESSWIRE / May 3, 2016 / Utah Medical Products, Inc. (Nasdaq: UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-six cents ($.26) per share of common stock payable on July 6, 2016 to shareholders of record at the close of business on June 17, 2016. This is a 2% increase over the dividend declared in the same quarter of the prior year.
UTMD: 64.61 (-0.46)
Utah Medical posts 1Q profit
Automated Insights - Tue Apr 26, 8:12AM CDT
MIDVALE, Utah (AP) _ Utah Medical Products Inc. (UTMD) on Tuesday reported first-quarter profit of $3.2 million.
UTMD: 64.61 (-0.46)
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2016
Marketwired - Tue Apr 26, 8:01AM CDT
In the first calendar quarter (1Q) of 2016, Utah Medical Products, Inc. (NASDAQ: UTMD) achieved results representing a solid start to meeting its previously announced goals for 2016.
UTMD: 64.61 (-0.46)
Utah Medical Products Reports Audited Financial Performance for Fourth Quarter and Year 2015
Marketwired - Tue Feb 02, 8:01AM CST
Utah Medical Products, Inc. (NASDAQ: UTMD) concluded a financial year in 2015 dominated by changes in foreign currency exchange (FX) rates. Despite a weak fourth calendar quarter (4Q) due to international distributor order patterns, revenues for the year were up 1% on a constant currency basis. Earnings per share (EPS) were also up 1% excluding a "windfall" increase in 4Q 2015 net profits that resulted from the UK again lowering corporate income tax rates.
UTMD: 64.61 (-0.46)
Postpartum Hemorrhage (PPH) Treatment Devices (NASG, Uniject Prefilled Injection System, Uterine Balloon Tamponade) Market - Global Industry Analysis 2015-2023
M2 - Mon Dec 07, 6:46AM CST
Research and Markets (http://www.researchandmarkets.com/research/p5zzrf/postpartum) has announced the addition of the "Postpartum Hemorrhage (PPH) Treatment Devices Market - Global Industry Analysis, Size, Growth, Trends and Forecast 2015 - 2023" report to their offering. This study provides a comprehensive analysis of the global postpartum hemorrhage treatment devices market and helps in recognizing several governing factors that impact the market both positively and negatively. Executive summary of the report captures comprehensive insights about every segment considered in this study. It includes a market snapshot offering an insight into the current scenario of the PPH treatment devices market in terms of current and future market size along with growth rate. The global postpartum hemorrhage treatment devices market has been segmented based on various products used across various geographies. The postpartum hemorrhage treatment devices market has been categorized into major products used for providing therapeutic treatment measures such as non-pneumatic anti-shock garment (NASG), the Uniject prefilled injection system, and uterine balloon tamponade. The uterine balloon tamponade segment has been further segmented into Foley catheters, condom catheters, and others (e.g. Bakri, Rusch, etc.). The market size for the period from 2013 to 2023 has been provided for each of the product categories mentioned above in terms of USD million. Factors such as ultra-low cost, easy availability, and high effectiveness have been attributed to the largest share of the uterine balloon tamponades segment. However, Uniject prefilled injection system is expected to grow at the fastest CAGR of over 5% during the forecast period due to factors such as increasing involvement of governmental organizations, easy applicability, equitable pricing, and growing product adoption. Key Topics Covered: Chapter 1 Preface Chapter 2 Executive Summary Chapter 3 Global Postpartum Hemorrhage Treatment Devices Market Overview Chapter 4 Global Postpartum Hemorrhage Treatment Devices Market, by Product Type Chapter 5 Global Postpartum Hemorrhage Treatment Devices Market, By Geography Chapter 6 Recommendations Chapter 7 Company Profiles - 3rd Stone Design, Inc. - Bactiguard AB - Cook Medical, Inc. - C. R. Bard, Inc. - Program for Appropriate Technology in Health (PATH) - Teleflex Incorporated - Utah Medical Products, Inc. - ZOEX NIASG For more information visit http://www.researchandmarkets.com/research/p5zzrf/postpartum
TFX: 180.33 (+0.02), UTMD: 64.61 (-0.46)
Smoke Evacuation System Market by Product, Application & End-User - Global Forecast to 2020
M2 - Mon Dec 07, 2:18AM CST
Research and Markets (http://www.researchandmarkets.com/research/mh4slh/smoke_evacuation) has announced the addition of the "Smoke Evacuation System Market - Global Forecast to 2020" report to their offering. The global smoke evacuation system market is estimated to grow at a CAGR of 5.6% from 2015 to 2020. Although mature markets (such as North America and Europe) hold larger shares in the market in 2015, the Asia-Pacific region is poised to grow at the highest CAGR of 7.1% in the next five years. Factors such as the growing popularity of cosmetic surgery, presence of a large patient population, government efforts to increase population access to elective surgeries, improving healthcare infrastructure, increasing disposable income, and rising medical tourism in emerging Asian countries are propelling the growth of the smoke evacuation system market in the Asia-Pacific region. The growth of the global smoke evacuation system market is driven by a number of factors such as the global rise in geriatric and obese populations, increasing number of surgeries, growing demand for minimally invasive surgeries, and increasing demand for smoke evacuators. In addition, emerging markets, growing number of hospitals and surgical centers, and recommendations for the use of smoke evacuation systems in operating rooms by various associations and organizations are creating new growth opportunities for manufacturers. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Smoke Evacuation System Market, By Product 7 Smoke Evacuation System Market, By Application 8 Smoke Evacuation System Market, By End User 9 Smoke Evacuation System Market, By Region 10 Competitive Landscape 11 Company Profiles - Bovie Medical Corporation - Buffalo Filter Llc (A Part Of Filtration Group Corporation Life Sciences Group) - Cls Surgimedics - Conmed Corporation - Coopersurgical Inc. (A Subsidiary Of The Cooper Companies, Inc.) - Covidien (A Subsidiary Of Medtronic Plc) - Erbe Elektromedizin Gmbh - I. C. Medical, Inc. - Megadyne Medical Products Inc. - Utah Medical Products, Inc. For more information visit http://www.researchandmarkets.com/research/mh...evacuation
MDT: 88.06 (+0.43), BVX: 1.87 (+0.02), UTMD: 64.61 (-0.46)
Utah Medical Products, Inc. Increases Quarterly Dividend
ACCESSWIRE - Tue Nov 03, 9:01AM CST
SALT LAKE CITY, UT / ACCESSWIRE / November 3, 2015 / Utah Medical Products, Inc. (Nasdaq: UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-six cents ($.26) per share of common stock payable on December 30, 2015 to shareholders of record at the close of business on December 16, 2015. This is a 2% increase over the prior quarterly cash dividend.
UTMD: 64.61 (-0.46)
Utah Medical Products, Inc. Reports Financial Performance for Third Quarter 2015
Marketwired - Thu Oct 22, 8:01AM CDT
In the third calendar quarter (3Q) and first nine months (9M) of 2015, Utah Medical Products, Inc.'s (NASDAQ: UTMD) changes in income statement results compared to the same time periods in the prior calendar year were as follows:
UTMD: 64.61 (-0.46)
Utah Medical Products Has Returned 6.2% Since SmarTrend Recommendation (UTMD)
Comtex SmarTrend(R) - Tue Aug 25, 11:27AM CDT
SmarTrend identified a Downtrend for Utah Medical Products (NASDAQ:UTMD) on July 29th, 2015 at $54.69. In approximately 4 weeks, Utah Medical Products has returned 6.19% as of today's recent price of $51.30.
UTMD: 64.61 (-0.46)
Global Electro Surgical Market 2015
M2 - Tue May 05, 5:56AM CDT
Research and Markets (http://www.researchandmarkets.com/research/gfvmqm/electro_surgical) has announced the addition of the "Electro Surgical Market" report to their offering. The global electrosurgical market is expected to achieve a CAGR of 7% for the forecast period. Minimal invasive surgery offer huge benefits for patients as well as surgeons such as fast recovery, fewer post surgery infections, condensed visible marks, bleeding control and improved accuracy are some of the major drivers of electro surgical market. Increasing risk of side effects from these electrosurgery devices is one of the major challenges hindering the market growth. Other factors consists of rising trends in purchasing in bulk through group health organizations and through integrated health networks which creates increasing price pressure on the market players. The budding markets including India, China, Brazil and Mexico became attractive for companies involved in this market. Increasing trends in medical tourism, government initiatives for development of modern health care systems, reimbursements and huge population base are some of the factors that attract the electrosurgical device market in emerging countries. Key Topics Covered: 1. Executive summary 2. Introduction 3. Market Analysis 4. Electrosurgical devices Market by Products 5. Electrosurgical devices Market by Surgery 6. Regional Market Analysis 7. Company Developments 8. Major Company Profiles - B. Braun Melsungen - Boston Scientific Corporation - Bovie Medical Corporation - ConMed Corporation - Johnson & Johnson (Ethicon) - Medtronic (Covidien) - Olympus Corpopration - Smith & Nephew Plc - Symmetry Surgical Inc - Utah Medical Products Inc For more information visit http://www.researchandmarkets.com/research/gf...o_surgical
BSX: 24.43 (+0.15), SNN: 33.18 (-0.11), JNJ: 125.40 (+0.17), MDT: 88.06 (+0.43), BVX: 1.87 (+0.02), SSRG: 13.18 (+0.05), UTMD: 64.61 (-0.46)
Utah Medical Products, Inc. Reports Financial Performance for Second Quarter 2016
Marketwire Canada - Tue Jul 26, 8:01AM CDT
SALT LAKE CITY, UT--(Marketwired - Jul 26, 2016) - In the second calendar quarter (2Q) and first half (1H) of 2016, Utah Medical Products, Inc. (NASDAQ: UTMD) continued to achieve results which are on track to meet its previously announced goals for 2016.
UTMD: 64.61 (-0.46)
Utah Medical Products, Inc. Announces Quarterly Dividend
ACCESSWIRE - Tue May 03, 9:00AM CDT
SALT LAKE CITY, UT / ACCESSWIRE / May 3, 2016 / Utah Medical Products, Inc. (Nasdaq: UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-six cents ($.26) per share of common stock payable on July 6, 2016 to shareholders of record at the close of business on June 17, 2016. This is a 2% increase over the dividend declared in the same quarter of the prior year.
UTMD: 64.61 (-0.46)
Utah Medical posts 1Q profit
Automated Insights - Tue Apr 26, 8:12AM CDT
MIDVALE, Utah (AP) _ Utah Medical Products Inc. (UTMD) on Tuesday reported first-quarter profit of $3.2 million.
UTMD: 64.61 (-0.46)
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2016
Marketwired - Tue Apr 26, 8:01AM CDT
In the first calendar quarter (1Q) of 2016, Utah Medical Products, Inc. (NASDAQ: UTMD) achieved results representing a solid start to meeting its previously announced goals for 2016.
UTMD: 64.61 (-0.46)
Utah Medical Products Reports Audited Financial Performance for Fourth Quarter and Year 2015
Marketwired - Tue Feb 02, 8:01AM CST
Utah Medical Products, Inc. (NASDAQ: UTMD) concluded a financial year in 2015 dominated by changes in foreign currency exchange (FX) rates. Despite a weak fourth calendar quarter (4Q) due to international distributor order patterns, revenues for the year were up 1% on a constant currency basis. Earnings per share (EPS) were also up 1% excluding a "windfall" increase in 4Q 2015 net profits that resulted from the UK again lowering corporate income tax rates.
UTMD: 64.61 (-0.46)
Postpartum Hemorrhage (PPH) Treatment Devices (NASG, Uniject Prefilled Injection System, Uterine Balloon Tamponade) Market - Global Industry Analysis 2015-2023
M2 - Mon Dec 07, 6:46AM CST
Research and Markets (http://www.researchandmarkets.com/research/p5zzrf/postpartum) has announced the addition of the "Postpartum Hemorrhage (PPH) Treatment Devices Market - Global Industry Analysis, Size, Growth, Trends and Forecast 2015 - 2023" report to their offering. This study provides a comprehensive analysis of the global postpartum hemorrhage treatment devices market and helps in recognizing several governing factors that impact the market both positively and negatively. Executive summary of the report captures comprehensive insights about every segment considered in this study. It includes a market snapshot offering an insight into the current scenario of the PPH treatment devices market in terms of current and future market size along with growth rate. The global postpartum hemorrhage treatment devices market has been segmented based on various products used across various geographies. The postpartum hemorrhage treatment devices market has been categorized into major products used for providing therapeutic treatment measures such as non-pneumatic anti-shock garment (NASG), the Uniject prefilled injection system, and uterine balloon tamponade. The uterine balloon tamponade segment has been further segmented into Foley catheters, condom catheters, and others (e.g. Bakri, Rusch, etc.). The market size for the period from 2013 to 2023 has been provided for each of the product categories mentioned above in terms of USD million. Factors such as ultra-low cost, easy availability, and high effectiveness have been attributed to the largest share of the uterine balloon tamponades segment. However, Uniject prefilled injection system is expected to grow at the fastest CAGR of over 5% during the forecast period due to factors such as increasing involvement of governmental organizations, easy applicability, equitable pricing, and growing product adoption. Key Topics Covered: Chapter 1 Preface Chapter 2 Executive Summary Chapter 3 Global Postpartum Hemorrhage Treatment Devices Market Overview Chapter 4 Global Postpartum Hemorrhage Treatment Devices Market, by Product Type Chapter 5 Global Postpartum Hemorrhage Treatment Devices Market, By Geography Chapter 6 Recommendations Chapter 7 Company Profiles - 3rd Stone Design, Inc. - Bactiguard AB - Cook Medical, Inc. - C. R. Bard, Inc. - Program for Appropriate Technology in Health (PATH) - Teleflex Incorporated - Utah Medical Products, Inc. - ZOEX NIASG For more information visit http://www.researchandmarkets.com/research/p5zzrf/postpartum
TFX: 180.33 (+0.02), UTMD: 64.61 (-0.46)
Smoke Evacuation System Market by Product, Application & End-User - Global Forecast to 2020
M2 - Mon Dec 07, 2:18AM CST
Research and Markets (http://www.researchandmarkets.com/research/mh4slh/smoke_evacuation) has announced the addition of the "Smoke Evacuation System Market - Global Forecast to 2020" report to their offering. The global smoke evacuation system market is estimated to grow at a CAGR of 5.6% from 2015 to 2020. Although mature markets (such as North America and Europe) hold larger shares in the market in 2015, the Asia-Pacific region is poised to grow at the highest CAGR of 7.1% in the next five years. Factors such as the growing popularity of cosmetic surgery, presence of a large patient population, government efforts to increase population access to elective surgeries, improving healthcare infrastructure, increasing disposable income, and rising medical tourism in emerging Asian countries are propelling the growth of the smoke evacuation system market in the Asia-Pacific region. The growth of the global smoke evacuation system market is driven by a number of factors such as the global rise in geriatric and obese populations, increasing number of surgeries, growing demand for minimally invasive surgeries, and increasing demand for smoke evacuators. In addition, emerging markets, growing number of hospitals and surgical centers, and recommendations for the use of smoke evacuation systems in operating rooms by various associations and organizations are creating new growth opportunities for manufacturers. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Smoke Evacuation System Market, By Product 7 Smoke Evacuation System Market, By Application 8 Smoke Evacuation System Market, By End User 9 Smoke Evacuation System Market, By Region 10 Competitive Landscape 11 Company Profiles - Bovie Medical Corporation - Buffalo Filter Llc (A Part Of Filtration Group Corporation Life Sciences Group) - Cls Surgimedics - Conmed Corporation - Coopersurgical Inc. (A Subsidiary Of The Cooper Companies, Inc.) - Covidien (A Subsidiary Of Medtronic Plc) - Erbe Elektromedizin Gmbh - I. C. Medical, Inc. - Megadyne Medical Products Inc. - Utah Medical Products, Inc. For more information visit http://www.researchandmarkets.com/research/mh...evacuation
MDT: 88.06 (+0.43), BVX: 1.87 (+0.02), UTMD: 64.61 (-0.46)
Utah Medical Products, Inc. Increases Quarterly Dividend
ACCESSWIRE - Tue Nov 03, 9:01AM CST
SALT LAKE CITY, UT / ACCESSWIRE / November 3, 2015 / Utah Medical Products, Inc. (Nasdaq: UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-six cents ($.26) per share of common stock payable on December 30, 2015 to shareholders of record at the close of business on December 16, 2015. This is a 2% increase over the prior quarterly cash dividend.
UTMD: 64.61 (-0.46)
Utah Medical Products, Inc. Reports Financial Performance for Third Quarter 2015
Marketwired - Thu Oct 22, 8:01AM CDT
In the third calendar quarter (3Q) and first nine months (9M) of 2015, Utah Medical Products, Inc.'s (NASDAQ: UTMD) changes in income statement results compared to the same time periods in the prior calendar year were as follows:
UTMD: 64.61 (-0.46)
Utah Medical Products Has Returned 6.2% Since SmarTrend Recommendation (UTMD)
Comtex SmarTrend(R) - Tue Aug 25, 11:27AM CDT
SmarTrend identified a Downtrend for Utah Medical Products (NASDAQ:UTMD) on July 29th, 2015 at $54.69. In approximately 4 weeks, Utah Medical Products has returned 6.19% as of today's recent price of $51.30.
UTMD: 64.61 (-0.46)
Global Electro Surgical Market 2015
M2 - Tue May 05, 5:56AM CDT
Research and Markets (http://www.researchandmarkets.com/research/gfvmqm/electro_surgical) has announced the addition of the "Electro Surgical Market" report to their offering. The global electrosurgical market is expected to achieve a CAGR of 7% for the forecast period. Minimal invasive surgery offer huge benefits for patients as well as surgeons such as fast recovery, fewer post surgery infections, condensed visible marks, bleeding control and improved accuracy are some of the major drivers of electro surgical market. Increasing risk of side effects from these electrosurgery devices is one of the major challenges hindering the market growth. Other factors consists of rising trends in purchasing in bulk through group health organizations and through integrated health networks which creates increasing price pressure on the market players. The budding markets including India, China, Brazil and Mexico became attractive for companies involved in this market. Increasing trends in medical tourism, government initiatives for development of modern health care systems, reimbursements and huge population base are some of the factors that attract the electrosurgical device market in emerging countries. Key Topics Covered: 1. Executive summary 2. Introduction 3. Market Analysis 4. Electrosurgical devices Market by Products 5. Electrosurgical devices Market by Surgery 6. Regional Market Analysis 7. Company Developments 8. Major Company Profiles - B. Braun Melsungen - Boston Scientific Corporation - Bovie Medical Corporation - ConMed Corporation - Johnson & Johnson (Ethicon) - Medtronic (Covidien) - Olympus Corpopration - Smith & Nephew Plc - Symmetry Surgical Inc - Utah Medical Products Inc For more information visit http://www.researchandmarkets.com/research/gf...o_surgical
BSX: 24.43 (+0.15), SNN: 33.18 (-0.11), JNJ: 125.40 (+0.17), MDT: 88.06 (+0.43), BVX: 1.87 (+0.02), SSRG: 13.18 (+0.05), UTMD: 64.61 (-0.46)
